AGIO

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AGIO
DateTimeSourceHeadlineSymbolCompany
09/10/202112:23PMEdgar (US Regulatory)Confidential Treatment Order (ct Order) NASDAQ:AGIOAgios Pharmaceuticals Inc
08/30/20217:00AMGlobeNewswire Inc.Agios To Present at September Investor Conferences NASDAQ:AGIOAgios Pharmaceuticals Inc
08/26/20218:33AMSeeking AlphaThermo Fisher wins FDA nod for companion diagnostic targeting specific bile-duct cancer NASDAQ:AGIOAgios Pharmaceuticals Inc
08/17/20214:01PMGlobeNewswire Inc.Agios Announces FDA Acceptance and Priority Review of New Drug Application for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency NASDAQ:AGIOAgios Pharmaceuticals Inc
08/09/20213:24PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a) NASDAQ:AGIOAgios Pharmaceuticals Inc
07/29/202110:57AMEdgar (US Regulatory)Quarterly Report (10-q) NASDAQ:AGIOAgios Pharmaceuticals Inc
07/29/20217:17AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AGIOAgios Pharmaceuticals Inc
07/29/20217:09AMSeeking AlphaAgios Pharmaceuticals EPS misses by $0.12 NASDAQ:AGIOAgios Pharmaceuticals Inc
07/29/20217:00AMGlobeNewswire Inc.Agios Reports Business Highlights and Second Quarter 2021 Financial Results NASDAQ:AGIOAgios Pharmaceuticals Inc
07/15/20217:00AMGlobeNewswire Inc.Agios to Webcast Conference Call of Second Quarter 2021 Financial Results on July 29, 2021 NASDAQ:AGIOAgios Pharmaceuticals Inc
06/28/20217:00AMGlobeNewswire Inc.Agios Submits Marketing Authorisation Application to European Medicines Agency for Mitapivat for Treatment of Adults with Pyr... NASDAQ:AGIOAgios Pharmaceuticals Inc
06/23/20215:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:AGIOAgios Pharmaceuticals Inc
06/22/20217:00AMGlobeNewswire Inc.Agios Launches myAgios® Patient Support Services for Pyruvate Kinase Deficiency NASDAQ:AGIOAgios Pharmaceuticals Inc
06/21/20214:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:AGIOAgios Pharmaceuticals Inc
06/21/20214:01PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AGIOAgios Pharmaceuticals Inc
06/21/20218:21AMSeeking AlphaAgios submits mitapivat application in U.S. for pyruvate kinase deficiency NASDAQ:AGIOAgios Pharmaceuticals Inc
06/21/20217:42AMDow Jones NewsAgios Files for FDA OK of Mitapivat in PK Deficiency NASDAQ:AGIOAgios Pharmaceuticals Inc
06/21/20217:00AMGlobeNewswire Inc.Agios Submits New Drug Application to FDA for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency NASDAQ:AGIOAgios Pharmaceuticals Inc
06/11/20215:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:AGIOAgios Pharmaceuticals Inc
06/11/20218:39AMSeeking AlphaAgios's mitapivat shows positive action in Phase 2 non-transfusion-dependent thalassemia study NASDAQ:AGIOAgios Pharmaceuticals Inc
06/11/20217:25AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AGIOAgios Pharmaceuticals Inc
06/11/20213:00AMGlobeNewswire Inc.Agios Presents Positive Results from Phase 2 Study of Mitapivat in Non-transfusion-dependent α- and β-Thalassemia at the Eu... NASDAQ:AGIOAgios Pharmaceuticals Inc
06/11/20213:00AMGlobeNewswire Inc.Agios Announces Updated Data from ACTIVATE and ACTIVATE-T Phase 3 Studies of Mitapivat in Pyruvate Kinase (PK) Deficiency at ... NASDAQ:AGIOAgios Pharmaceuticals Inc
06/09/20214:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:AGIOAgios Pharmaceuticals Inc
06/02/20214:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:AGIOAgios Pharmaceuticals Inc
06/02/20214:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:AGIOAgios Pharmaceuticals Inc
06/02/20214:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:AGIOAgios Pharmaceuticals Inc
06/02/20214:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:AGIOAgios Pharmaceuticals Inc
05/24/20214:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:AGIOAgios Pharmaceuticals Inc
05/24/20214:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:AGIOAgios Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AGIO
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20210920 07:26:59